AUTOLUS THERAPEUTICS PLC (AUTL)
US05280R1005 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 239.57M | 382.40M | 310.30M | 153.30M | 210.60M | |||
| Receivables | 24.54M | 29.00M | 26.30M | 29.70M | 30.50M | |||
| Other Current Assets | 11.19M | 14.30M | 10.40M | 14.00M | 8.10M | |||
| Total Current Assets | 275.30M | 425.80M | 347.00M | 197.00M | 249.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 95.65M | 58.40M | 52.30M | 89.70M | 51.60M | |||
| Intangibles | N/A | 0.00 | 100.00K | 200.00K | 300.00K | |||
| Other Non-Current Assets | 4.43M | 6.10M | 6.20M | 7.40M | 2.50M | |||
| Total Non-Current Assets | 100.08M | 64.50M | 58.60M | 97.20M | 54.20M | |||
| TOTAL ASSETS | 375.38M | 490.30M | 405.60M | 294.20M | 303.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 44.10M | 45.40M | 28.00M | 30.90M | 22.80M | |||
| Accounts Payable | 103.00K | 500.00K | 400.00K | 2.30M | 1.10M | |||
| Other Current Liabilities | 533.00K | 400.00K | 200.00K | 500.00K | 1.10M | |||
| Total Current Liabilities | 44.74M | 46.40M | 28.60M | 33.60M | 25.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 219.17M | 145.20M | 63.70M | 50.60M | 23.70M | |||
| Total Non-Current Liabilities | 219.17M | 145.20M | 63.60M | 50.60M | 23.70M | |||
| TOTAL LIABILITIES | 263.91M | 191.60M | 92.20M | 84.20M | 48.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -878.56M | -670.20M | -521.30M | -379.20M | -237.20M | |||
| Additional Paid In Capital | 1.02B | 1.01B | 843.10M | 595.00M | 500.60M | |||
| Common Shares | 126.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -28.99M | -38.90M | -8.60M | -5.90M | -8.70M | |||
| Shares Outstanding | N/A | 172.33M | 90.51M | 52.25M | 44.95M | |||
| Tangible Book Value per Share | 111.47 | 298.67 | 313.25 | 4.01 | 5.66 | |||
| Total Shareholders' Equity | 111.47M | 298.70M | 313.30M | 210.00M | 254.80M | |||
| TOTAL LIABILITIES AND EQUITY | 375.38M | 490.30M | 405.60M | 294.20M | 303.50M | |||
| Statistics | ||||||||
| Current Ratio | 6.15 | 9.18 | 12.13 | 5.86 | 9.97 | |||
| Return On Assets (ROA) | -55.51% | -30.36% | -35.03% | -48.30% | -40.81% | |||
| Return On Equity (ROE) | -186.93% | -49.83% | -45.36% | -67.66% | -48.61% | |||
All data in USD